Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Impressive results with long COVID pacing trial
A pacing rehabilitation programme that helps people with long COVID reduce their symptoms and increase activity levels has shown “impressive” results, say scientists.
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer
One in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it, new research has found.
First-wave COVID-19 linked to long-term depressive symptoms
People who reported contracting COVID-19 early in the pandemic were twice as likely to experience depressive symptoms 13 months later than those who did not, new research has found.
Preventing European cancer epidemic
Europe will face a cancer epidemic in the next decade if weaknesses in cancer health systems and cancer research are not urgently addressed, say the authors of a major new report.